We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

An Audit on Management of Chronic Diarrhea (AAOMOCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03269305
Recruitment Status : Completed
First Posted : August 31, 2017
Last Update Posted : December 8, 2020
Assiut University
Information provided by (Responsible Party):
Gehad Adel Mohammed, Assiut University

Brief Summary:
The study is to assess whether the staff in gastroenterology unit are sticking to the agreed up on unit's protocol in management of chronic diarrhea over the period of one year(september 2017-september 2018)

Condition or disease
Chronic Diarrhea

Detailed Description:

chronic diarrhea is defined as having loose or watery stools more than three times aday.Awakening at night to pass stools us often sign of an organic cause of diarrhea.In some cases chronic diarrhea is the result of intestinal infection that persists longer than expected. In other cases chronic diarrhea is apart of a systemic illness.


  1. post enteritis diarrhea syndrome in whic small intestinal mucosal damage persists after acute gastroenteritis.Also secondary disaccharidase deficiency and reinfection may be a cause.
  2. infectious causes:enteric infection is an important cause.Associated conditions may be T.B or impaired immunity as in malnutrition potentiating the likely-hood of prolonging or acquiring another infection.Viral infection like Rota virus,parasites as E.coli,Giardia lamblia as well as amebiasis have been implicated in chronic diarrhea.
  3. Cytomegalovirus on the other hand may act as an opportunistic agent in immuno compromised patients.
  4. Non infectious causes include cow's milk allergy,lactose intolerance and inflammatory bowel disease,all of which may cause chronic diarrhea that is often associated with abdominal pain with or without elevated levels of inflammatory markers.
  5. Malabsorption syndrome e.g Celiac disease,cystic fibrosis where the stools are usually fatty in nature and bulky in amount.

Good management of chronic diarrhea must include investigations and treatment.A protocol must be followed accurately therefore.


measurment of the degree of sticking of staff in Gastro-enterology unit to the agreed upon unit's protocol in management of chronic diarrhea over the period of one year (September 2017-September 2018).

Layout table for study information
Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: An Audit on Management of Chronic Diarrhea
Actual Study Start Date : September 1, 2017
Actual Primary Completion Date : September 1, 2018
Actual Study Completion Date : September 1, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Diarrhea

Primary Outcome Measures :
  1. proper management of chronic diarrhea [ Time Frame: september 2017-september 2018 ]

    start accurate treatment of chronic diarrhea by reaching a definitive cause of each case .

    decrease the incidence of undiagnosed cases of chronic diarrhea

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Months to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
an audit

Inclusion Criteria:

  • age group from 2 months to 18 years
  • cases with diarrhea lasts 2 weeks or more
  • Genetically free

Exclusion Criteria:

  • age group from 0-2 months
  • age group above 18 years
  • cases with diarrhea less than 2 weeks
  • Gentic disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03269305

Layout table for location information
Assiut, Egypt
Sponsors and Collaborators
Gehad Adel Mohammed
Assiut University
Layout table for investigator information
Study Director: Faisal Alkhateeb, Phd Assiut University
Layout table for additonal information
Responsible Party: Gehad Adel Mohammed, principal investigator, Assiut University
ClinicalTrials.gov Identifier: NCT03269305    
Other Study ID Numbers: AssiutU71515
First Posted: August 31, 2017    Key Record Dates
Last Update Posted: December 8, 2020
Last Verified: November 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Signs and Symptoms, Digestive